Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axogen Inc
(NQ:
AXGN
)
14.71
+1.11 (+8.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Axogen Inc
< Previous
1
2
Next >
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
September 06, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
September 03, 2024
From
Axogen, Inc.
Via
GlobeNewswire
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
August 13, 2024
CytoSorbents CFO Kathleen P. Bloch Retires
From
CytoSorbents
Via
GlobeNewswire
Axogen, Inc. Announces New Leadership Appointments
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
July 23, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
July 01, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
June 24, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
May 28, 2024
Showcasing Axogen’s Dedication to Fueling Ohio’s Biotechnology Sector Growth
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
May 16, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
May 14, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc Reports First Quarter 2024 Financial Results
May 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
April 29, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 16, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
March 05, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
February 13, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
January 18, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Promotions on Research and Development Team
January 04, 2024
Company Also Announces Departure of Angelo Scopelianos, Ph.D.
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
December 26, 2023
Weiler brings 20+ years of strategic and commercial leadership experience to the Axogen, Inc. Board of Directors
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Transition of Finance Team Leadership
December 06, 2023
Nir Naor Appointed CFO to Replace Peter Mariani as Company Aligns Executive Team with Financial Management Needs for Next Phase of Growth
From
Axogen, Inc.
Via
GlobeNewswire
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Reports 2023 Third Quarter Financial Results
November 07, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023
October 18, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™
September 05, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at Upcoming Investor Conferences
August 31, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
August 21, 2023
From
Axogen, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.